FIGURE 1.

Flowchart of patients with stage III and stage IV melanoma selected for serum/plasma analyses. Number of patients included for the different analysis. A total of 117 patients with paired plasma/serum samples were available at stage III disease and stage IV disease (paired analysis). Because of plasma/serum mismatch and heterogeneity between samples from European centers and MIA, the sera of 65 patients were used for analysis. Of these patients, 33 patients were analyzed by Olink and 64 patients were analyzed by MS (left). Plasma of 108 patients with stage III or stage IV was analyzed by Olink (right).